There’s nothing like the heartbreak of losing someone to Alzheimer’s, Parkinson’s or M.S. And if you have a history of those diseases in your family you can’t help but wonder how you can spare your loved ones the same trauma. It is estimated that 5 million Americans are living with Alzheimer’s, 1 million are living with Parkinson’s, and 30,000 with Huntington’s, with many more at risk. New studies show CBD oils like Swissx are helping stop progressive memory loss, reducing spasticity of all kinds, and helping to calm the anxiety that comes from fighting the symptoms and fear associated with these problems.
According to the National Center for Biotechnology Information, even these diseases that seem so complicated are linked to inflammation: “Neurodegenerative diseases are characterized by a loss of neurons in particular regions of the nervous system. It is believed that this nerve cell loss underlies the subsequent decline in cognitive and motor function that patients experience in these diseases. A range of mutant genes and environmental toxins have been implicated in the cause of neurodegenerative disorders but the mechanism remains largely unknown. At present, inflammation, a common denominator among the diverse list of neurodegenerative diseases, has been implicated as a critical mechanism that is responsible for the progressive nature of neurodegeneration. “
And, so, once again CBD oils are called for, citing the NCBI again: “Since, at present, there are few therapies for the wide range of neurodegenerative diseases, scientists are still in search of new therapeutic approaches to the problem. An early contribution of neuroprotective and anti-inflammatory strategies for these disorders seems particularly desirable because isolated treatments cannot be effective. In this contest, marijuana derivatives have attracted special interest, although these compounds have always raised several practical and ethical problems for their potential abuse. Nevertheless, among Cannabis compounds, cannabidiol (CBD), which lacks any unwanted psychotropic effect, may represent a very promising agent with the highest prospect for therapeutic use.”A key hallmark of Alzheimer’s disease is the build-up of clumps of a protein, called amyloid, in the brain. Some studies have shown that CBD oils appear to remove this protein from nerve cells grown in the lab.
Another study that gave CBD oil to mice with symptoms of Alzheimer's disease showed an improved in learning and had less evidence of amyloid clumps in their bodies. At the very least research does suggest that high concentrations of CBD oil could be useful for managing some of the symptoms of dementia such as agitation and anxiety.